These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1568412)

  • 21. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
    Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
    Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
    Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
    Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies.
    Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI
    Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis.
    Esteban JM; Yokota S; Husain S; Battifora H
    Am J Clin Pathol; 1990 Dec; 94(6):698-705. PubMed ID: 1700877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.
    Linari A; Bussolati G
    J Clin Pathol; 1989 Nov; 42(11):1184-9. PubMed ID: 2685053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
    Stoetzer OJ; Munker R; Darsow M; Wilmanns W
    Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A panel of markers for identification of malignant and non-malignant cells in culture from effusions.
    Carneiro FP; Muniz-Junqueira MI; Pittella-Silva F; Carneiro MV; Takano GHS; Vianna LMS; De Andrade LB; De Castro TMML; Peres I; Dos Santos Borges TK; Ferreira VM; Motoyama AB
    Oncol Rep; 2017 Dec; 38(6):3538-3544. PubMed ID: 29039588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
    Grefte JM; de Wilde PC; Salet-van de Pol MR; Tomassen M; Raaymakers-van Geloof WL; Bulten J
    Acta Cytol; 2008; 52(1):35-44. PubMed ID: 18323273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of tumor-associated antigens and total sialic acid levels in effusions of malignant and benign origin.
    Yenisey C; Yenice S; Güner G; Güner S
    Biochem Soc Trans; 1996 May; 24(2):301S. PubMed ID: 8736959
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values.
    Zhang KH; Cao F; Fu QB; Zhu JQ; Chen J; Lv NH
    Intern Med; 2007; 46(18):1489-94. PubMed ID: 17878632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
    Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
    Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
    Pillai V; Cibas ES; Dorfman DM
    Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors.
    Mottolese M; Salzano M; Vincenzoni C; Benevolo M; Bigotti A; Iacovelli A; Lombardi A; Atlante G; Natali PG
    Cancer; 1991 Oct; 68(8):1803-7. PubMed ID: 1833045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
    Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
    Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.